Ameriprise
ECTE

Ameriprise’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Ameriprise’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-200
Closed – – 4973
2014
Q3 		$0 Hold
200
– – ﹤0.01% 5996
2014
Q2 		$0 Buy
+200
New +$497 ﹤0.01% 5771

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Ameriprise's ECTE Position: Q4 2014 in Review

Ameriprise sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q4 2014, closing a stake of 200 shares.

Ameriprise first reported a position in ECTE in Q2 2014 and held it in 2 quarters. The position peaked at $0 in Q3 2014. 17 funds tracked by Wall St. Rank hold ECTE as of Q4 2014.

  • Ameriprise reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 200 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q4 2014.
  • Ameriprise first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2014 and held it in 2 quarters.
  • Ameriprise's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $0 in Q3 2014.
  • 17 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.